申请人:BAYER PHARMA AG
公开号:WO2016202935A1
公开(公告)日:2016-12-22
The present invention relates to quinoline-4-carboxamide derivatives of Formula (I) that selectively inhibit glucose transporter 1 (GLUT1), to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.
本发明涉及选择性抑制葡萄糖转运蛋白1(GLUT1)的式(I)的喹啉-4-甲酰胺衍生物,以及制备该化合物的方法,包括含有该化合物的药物组合物和配方,用于制造用于治疗或预防疾病的药物组合物的药物组合物,以及用于制备该化合物的中间化合物。